Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes.
Diabetic retinopathy is the most common microvascular complication caused by diabetes mellitus and is a leading cause of vision loss among working-age adults in developed countries. Understanding the effects of diabetes on the retinal proteome may provide insights into factors and mechanisms responsible for this disease. We have performed a comprehensive proteomic analysis and comparison of retina from C57BL/6 mice with 2 months of streptozotocin-induced diabetes and age-matched nondiabetic control mice. To explore the role of the angiotensin AT1 receptor in the retinal proteome in diabetes, a subgroup of mice were treated with the AT1 antagonist candesartan. We identified 1792 proteins from retinal lysates, of which 65 proteins were differentially changed more than 2-fold in diabetic mice compared with nondiabetic mice. A majority (72%) of these protein changes were normalized by candesartan treatment. Most of the significantly changed proteins were associated with metabolism, oxidative phosphorylation, and apoptotic pathways. An analysis of the proteomics data revealed metabolic and apoptotic abnormalities in the retina from diabetic mice that were ameliorated with candesartan treatment. These results provide insight into the effects of diabetes on the retina and the role of the AT1 receptor in modulating this response.
Research Division, Joslin Diabetes Center, One Joslin Place, Boston, Massachusetts 02215, USA.
Ben-Bo
BB
Gao
Joanna A
JA
Phipps
Dahlia
D
Bursell
Allen C
AC
Clermont
Edward P
EP
Feener
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D017209:Apoptosis; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D001713:Biphenyl Compounds; D003920:Diabetes Mellitus / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000378:metabolism*; D005136:Eye Proteins / Q000032:analysis* / Q000378:metabolism; D008660:Metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010085:Oxidative Phosphorylation; D020543:Proteome / Q000187:drug effects*; D040901:Proteomics; D012160:Retina / Q000737:chemistry*; D013311:Streptozocin; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D005136:Eye Proteins; D020543:Proteome; D013777:Tetrazoles; D013311:Streptozocin; C081643:candesartan